Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice

Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh

Clin Mol Hepatol. 2013;19(1):60-69. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.60

View: 8434 Download: 61 Web of Science: 6 Crossref: 7

4

A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin

Youn Ho Kim , Woo Sik Han , Sun Jae Lee , Sung Nam Oh , Do Won Choi , Kwan Soo Byun , Jong Eun Yeon

Clin Mol Hepatol. 2007;13(3):419-422. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.419

View: 4112 Download: 18

Pulmonary Toxicity by Pegylated Interferon α-2a in a Patient with Chronic Hepatitis C

Byoung Kwan Son , Joo Hyun Sohn , Tae Yeob Kim , Yoon Kyung Park , Yong Chul Jeon , Dong Soo Han

Clin Mol Hepatol. 2007;13(1):103-107. Published online January 1, 1970

View: 2713 Download: 19

1 |

Viewed By 5336	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5287	MAFLD: How is it different from NAFLD?
Viewed By 5176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3880	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3831	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search